Drugs / IL-4PE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00797940 | Jan 2009 → Dec 2010 | glioblastoma | Sophiris Bio Corp | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IL-4PE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00797940 ↗ |
| Route | Other | “intratumoral infusion” NCT00797940 ↗ |